SANTA ANA, Calif. — FUJIFILM Irvine Scientific has officially changed its legal name to FUJIFILM Biosciences Inc., effective January 1, 2026, marking the completion of a rebrand announced in June as part of a broader restructuring within the Fujifilm Life Sciences Group.
The new name reflects the company’s evolution from a cell culture media pioneer into a provider of a full spectrum of life sciences solutions, building on more than 55 years of experience in the industry. The company said the rebrand underscores its expanded role serving a wider life sciences community while maintaining its longstanding focus on people, innovation, and quality.
FUJIFILM Biosciences said it remains committed to empowering scientists and researchers across all stages of discovery, development, and commercialization. Its portfolio includes cell culture media, feeds, specialty chemicals and reagents, single-use technologies, and human-induced pluripotent stem cell capabilities, aimed at supporting the development of therapies that can improve patient outcomes worldwide.
“All of us at FUJIFILM Biosciences take immense pride in being a people-focused company that empowers our colleagues to create an exceptional customer experience,” said Brandon Pence, president and chief operating officer. “We utilize our 55-year legacy of deep industry knowledge to collaboratively develop innovative solutions and technologies that are supplied from our global network of manufacturing facilities. With this approach and our ongoing investments, we look ahead to a strong future with our employees, customers, and partners around the world.” (Source: IANS)
